Interleukin-18 in patients with congestive heart failure: induction of atrial natriuretic peptide gene expression

Res Commun Mol Pathol Pharmacol. 2000 Jul-Aug;108(1-2):87-95.

Abstract

Activated inflammatory responses appear to play a role in the development of congestive heart failure (CHF). We investigated interleukin-18 (IL-18), which is a cytokine synthesized by activated macrophage, changes in patients with CHF. We evaluated 11 Japanese patients with angina pectoris (n=4) or CHF (n=7). Blood was sampled immediately after admission and at 1, 2, 3, 6, and 9 hours after admission and then every 12 hours until 5 days after admission. Plasma IL-18 concentrations were measured by an enzyme-linked immunosorbent assay. Expression of atrial natriuretic peptide (ANP) mRNA and protein synthesis was examined in cardiac myocyte by stimulation of IL-18. Plasma IL-18 concentration was significantly higher in patients with CHF than in 15 healthy volunteers (51+/-21 pg/mL, and 28+11 pg/mL, respectively, P<0.05). Increased expression of ANP mRNA was demonstrated in IL-18 treated myocytes. Protein synthesis in myocytes was increased by IL-18 in a dose-dependent manner. Increased secretion of IL-18 is induced in patients with CHF and correlates with the severity of myocardial damage and dysfunction.

MeSH terms

  • Adult
  • Animals
  • Atrial Natriuretic Factor / biosynthesis*
  • Atrial Natriuretic Factor / genetics
  • Biomarkers
  • Cardiomegaly / blood
  • Cells, Cultured
  • Female
  • Gene Expression Regulation / physiology*
  • Heart Failure / blood*
  • Humans
  • Interleukin-18 / blood*
  • Male
  • Middle Aged
  • Muscle Proteins / biosynthesis
  • Myocardium / metabolism
  • RNA, Messenger / biosynthesis
  • Rats

Substances

  • Biomarkers
  • Interleukin-18
  • Muscle Proteins
  • RNA, Messenger
  • Atrial Natriuretic Factor